How stable is the hepatitis C virus (HCV)? environmental stability of HCV and its susceptibility to chemical biocides

Journal of Infectious Diseases

Volumn 201, Issue 12, 2010, Pages 1859-1866

  Ciesek, Sandra ^a,b   Friesland, Martina ^a   Steinmann, Jörg ^c   Becker, Britta ^d   Wedemeyer, Heiner ^b   Manns, Michael P ^b   Steinmann, Jochen ^d   Pietschmann, Thomas ^a   Steinmann, Eike ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d MikroLab GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ALCOHOL; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BIOCIDE; DISINFECTANT AGENT; PROPANOL; VIRUS RNA;

ACCURACY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE TECHNIQUE; DILUTION; DRUG ACTIVITY; DRUG SENSITIVITY; ENVIRONMENTAL FACTOR; GENETIC TRANSFECTION; GENOMIC INSTABILITY; HAND; HEPATITIS C VIRUS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; SERUM; SURFACE PROPERTY; TEMPERATURE; VIRUS CULTURE; VIRUS INFECTIVITY; CELL LINE; DRUG EFFECT; GENETICS; HUMAN; MICROBIAL VIABILITY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VIRUS INACTIVATION;

CELL LINE; DISINFECTANTS; HEPACIVIRUS; HUMANS; MICROBIAL VIABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TEMPERATURE; TIME FACTORS; TRANSFECTION; VIRUS INACTIVATION;

EID: 77952572492     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652803     Document Type: Article

References (36)

1. Manns MP, Foster GR, Rockstroh JK, Zeuzem S, Zoulim F, Houghton M. The way forward in HCV treatment: finding the right path. Nat Rev Drug Discov 2007; 6: 991-1000.
2. Santantonio T, Medda E, Ferrari C, et al Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 2006; 43: 1154-1159. (Pubitemid 44632798)
3. Martinez-Bauer E, Forns X, Armelles M, et al. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol 2008; 48: 20-27. (Pubitemid 350199575)
4. Deterding K, Wiegand J, Gruner N, Wedemeyer H. Medical procedures as a risk factor for HCV infection in developed countries: do we neglect a significant problem in medical care? J Hepatol 2008; 48: 1019-20; author reply 1020-1021.
5. Deterding K, Wiegand J, Gruner N, et al. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection. Z Gastroenterol 2009; 47: 531-540.
6. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-560. (Pubitemid 26066128)
7. Desenclos JC, Bourdiol-Razes M, Rolin B, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by springloaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001; 22: 701-707. (Pubitemid 34132011)
8. Macedo de Oliveira A, White KL, Leschinsky DP, et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005; 142: 898-902.
9. Bartenschlager R, Frese M, Pietschmann T. Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 2004; 63: 71-180. (Pubitemid 39752303)
10. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-796. (Pubitemid 41021213)
11. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623-626. (Pubitemid 41033648)
12. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 2005; 102: 9294-9299. (Pubitemid 40923557)
13. Buckwold VE, Beer BE, Donis RO. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res 2003; 60: 1-15. (Pubitemid 37153391)
14. Pietschmann T, Kaul A, Koutsoudakis G, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 2006; 103: 7408-7413. (Pubitemid 43727846)
15. Yanagi M, Purcell RH, Emerson SU, Bukh J. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic la and 2a chimeras. Virology 1999; 262: 250-263. (Pubitemid 29455022)
16. Koutsoudakis G, Kaul A, Steinmann E, et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 2006; 80: 5308-5320. (Pubitemid 43752776)
17. Gottwein JM, Scheel TK, Jensen TB, et al. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 2009; 49: 364-377.
18. Steinmann E, Brohm C, Kallis S, Bartenschlager R, Pietschmann T. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 2008; 82: 7034-7046. (Pubitemid 351977723)
19. Spearman C. The method of "right and wrong cases" ("constant stimuli") without Gausss formulae. Br J Psychol 1908; 2: 227-242.
20. Siegl G, Weitz M, Kronauer G. Stability of hepatitis A virus. Intervirology 1984; 22: 218-226.
21. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 1931; 162: 480-487.
22. Lock G, Dirscherl M, Obermeier F, et al. Hepatitis C- contamination of toothbrushes: myth or reality? J Viral Hepat 2006; 13: 571-573.
23. Sawayama Y, Hayashi J, Kakuda K, et al. Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. Dig Dis Sci 2000; 45: 351-356. (Pubitemid 30133898)
24. Akhtar S, Moatter T, Azam SI, Rahbar MH, Adil S. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hepat 2002; 9: 309-314. (Pubitemid 36002467)
25. Bronowicki JP, Venard V, Botte C, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997; 337: 237-240. (Pubitemid 27310439)
26. Gottwein JM, Bukh J. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Adv Virus Res 2008; 71: 51-133.
27. Sattar SA. Microbicides and the environmental control of nosocomial viral infections. J Hosp Infect 2004; 56(suppl 2): S64-S69.
28. Mailliard ME, Capadano ME, Hrnicek MJ, Gilroy RK, Gulizia JM. Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C. Hepatology 2009; 50: 361-368.
29. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week . Lancet 1981; 1: 550-551.
30. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007; 28: 519-524. (Pubitemid 46814539)
31. Meyer MF, Lehmann M, Cornberg M, et al. Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response. Virol J 2007; 4: 58.
32. Nascimbeni M, Mizukoshi E, Bosmann M, et al. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003; 77: 4781-4793. (Pubitemid 36402828)
33. Ruiz-Extremera A, Salmeron J, Torres C, et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virusnegative women: the role of breast-feeding in transmission. Pediatr Infect Dis J 2000; 19: 511-516. (Pubitemid 30409476)
34. Nuanualsuwan S, Cliver DO. Pretreatment to avoid positive RT-PCR results with inactivated viruses. J Virol Methods 2002; 104: 217-225. (Pubitemid 34667103)
35. Nuanualsuwan S, Cliver DO. Infectivity of RNA from inactivated poliovirus. Appl Environ Microbiol 2003; 69: 1629-1632.
36. Baert L, Vandekinderen I, Devlieghere F, Van Coillie E, Debevere J, Uyttendaele M. Inactivation of murine norovirus 1 and Bacteroides fragilis infecting phage B40-8 by the use of sodium hypochlorite and peroxyacetic acid as decontaminating agents for shredded iceberg lettuce. Commun Agric Appl Biol Sci 2008; 73: 97-101.